The nation of Zimbabwe has turned down a major US health deal valued at 367 million US dollars (£272m) over five years because of Washington's insistence on sensitive biological samples.
This rejection was revealed after a official document from December was leaked, which showed President Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesman later stated that the United States was seeking genetic material for scientific study and profit while refused to share the benefits from future vaccines.
"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for further dialogue to find a agreement acceptable to all parties so the nation's critical HIV treatment initiative can continue.
Broader Context
This rejection comes after a similar case in neighbouring Kenya, where a court blocked a related deal with the US following legal challenges were filed about the security of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
USAID had managed aid for the American government, but Trump argued its spending was "inefficient" and his administration was seeking direct bilateral agreements to enhance openness and accountability.
Based on reports, 16 nations in Africa have to date signed these new health pacts, representing more than $18.3bn in new funding.
Details of the Rejected Agreement
The funds for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration could have provided significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment via American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no corresponding assurance of access to any medical innovations – like new medicines or tests – that might be developed from that provided information," Mangwana explained.
"Effectively, our country would supply the raw materials for scientific discovery with no certainty that the end products would be available to our people should a future pandemic arise."
National Interest and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its push of bilateral deals were disrupting systems previously set up via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This framework is intended to guarantee that when a country contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to create them."
These objections over the US deal "are not meant as opposition to America," he added.
"We encourage ongoing dialogue with our US partners on how future collaboration might be structured in a way that respects the sovereignty and interests of both nations."
Medical Community Reaction
A leading public health body stated it acknowledged the government's concerns, but recommended that negotiations must proceed considering a large portion of the country's Aids initiatives depended on international support.
"If technical issues arise, including those involving data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," it added.
This impasse highlights the ongoing tensions between receiving much-needed foreign assistance and safeguarding local interests in an increasingly interconnected world.